Avenzo Therapeutics
Operator of a clinical-stage oncology platform intended to develop novel treatments for underserved cancers. The company's platform offers a pipeline of oncology drug candidates, focusing on rare and ...
Valuation
$590M
Market implied
Share Price
N/A
Total Raised
$445.9M
Last Round
N/A